Day: February 24, 2022

SUNNYVALE, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2021. “Our team and physicians had a tremendous impact in 2021, performing nearly 14,000 cases and driving record annual revenue of $101.5 million,” said Erica Rogers, President and Chief Executive Officer of Silk Road Medical. “We drove measurable progress on regulatory and clinical fronts in anticipation of standard surgical risk approval in the U.S., entry into Japan and China, and development of our long-term pipeline, and we are well positioned to continue establishing TCAR as the new standard of care in carotid artery disease through 2022 and beyond.” Fourth Quarter 2021...

NDA submission of sparsentan in IgA nephropathy on-track for first quarter 2022 Company positioned for potential NDA submission for accelerated approval of sparsentan in FSGS and combined IgA nephropathy and FSGS MAA submission mid-year 2022 Recently reported positive topline results from the ongoing Phase 1/2 COMPOSE Study of pegtibatinase in classical homocystinuria Net product sales increased six percent to $211 million for the full year 2021 SAN DIEGO, Feb. 24, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2021 financial results and provided a corporate update.The Company is on-track to submit a New Drug Application (NDA) for accelerated approval of sparsentan in IgA nephropathy (IgAN) in the first quarter of 2022 Preparations underway to submit NDA for...

SCOTTSDALE, Ariz., Feb. 24, 2022 (GLOBE NEWSWIRE) — TPI Composites, Inc. (Nasdaq: TPIC), today reported financial results for the fourth quarter and full year ended December 31, 2021. “We achieved record net sales in 2021 despite the ongoing challenges the broader wind industry faced, including supply chain costs and constraints, logistics costs and the lingering effects of COVID,” said Bill Siwek, President and CEO of TPI Composites. “Our results of operations for 2021 and the fourth quarter were adversely impacted by approximately $52 million and $40 million, respectively, primarily due to deferral of revenue relating to extensions of our customer contracts and estimates of costs to complete these contracts under ASC 606. However, these factors did not impact our 2021 billings, which exceeded expectations for 2021 and the fourth...

Announced completion of pre-BLA meeting with the FDA for omburtamab BLA resubmission expected by the end of first quarter 2022 DANYELZA® adoption drives sequential revenue increase Completed IND submission to the FDA for first SADA construct Appointed Sue Smith as Chief Commercial Officer Strong cash position with $181.6 million as of December 31, 2021, providing runway through the end of 2023 The Company will host a conference call on Friday, February 25, 2022, at 9 a.m. ESTNEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today reported financial results for the fourth quarter and the full year...

New York, NY, Feb. 24, 2022 (GLOBE NEWSWIRE) — iQSTEL, Inc. (OTCQX: IQST) today released another in an ongoing series of shareholder updates from CEO Leandro Iglesias as the company progresses toward its Nasdaq uplisting objective.  The letter is included in its entirety below. Dear Shareholders: Even though the geopolitical situation in Europe is complicated by the war in Ukraine, our company is running better and better. We are on track to reach our business goals for this Fiscal Year $90 Million Revenue and reach Net Income Positive, let’s review our business lines: Telecommunications: With $6.7 Million in revenue in January, and the synergistic strategies in place between subsidiaries, our Telecom Business Line remains the flagship of our company. Internet of Things: Our business development team, in addition to the installation...

 LONDON, February 24, 2022 – Stolt-Nielsen Limited (Oslo Børs: SNI) announced today that the Company’s Board of Directors recommended a final dividend for 2021 of $0.50 per Common Share, payable on May 11, 2022 to shareholders of record as of April 27, 2022. The shares will trade ex-dividend on and after April 26, 2022. The dividend, which is subject to shareholder approval, will be voted on at the Company’s Annual General Meeting of Shareholders scheduled for April 21, 2022 in Bermuda. If approved, this will bring the full dividend for 2021 to $1.00 per Common Share For additional information please contact: Jens F. Grüner-HeggeChief Financial OfficerU.K. +44 (0) 20 7611 8985j.gruner-hegge@stolt.com Ellie DavisonHead of Corporate CommunicationsU.K. +44 (0) 20 7611 8926e.davison@stolt.com   About Stolt-Nielsen LimitedStolt-Nielsen ...

PHOENIX, Feb. 24, 2022 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Mobivity Holdings Corp. (OTCQB: MFON), please note in the third paragraph, the short code was incorrect, as well as the link to the Ben’s Chili Bowl’s loyalty program. Additionally, the subheadline of the release has been removed and in the About Ben’s Chili Bowl section, the spelling of Dave Chappelle has been corrected. The corrected release follows: In recognition of National Chili Day, Washington, D.C. landmark Ben’s Chili Bowl today announced it has selected Mobivity Holdings Corp. (OTCQB: MFON), a global provider of personalized guest engagement solutions that drive customer frequency and spend, to make it easier to connect with its guests on the device they use the most. Mobivity SmartMessage helps restaurants use one-to-one...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. During the second quarter of 2021, Terranet AB (“Terranet” or the “Company”) issued warrants of series TO4 B and TO5 B. Each warrant entitles the holder the right to subscribe for one (1) new B share in the Company. The exercise price for the warrants of series TO4 B is to be determined to 70 percent of the volume-weighted average price in the Company’s share on Nasdaq First North Premier Growth Market during the measurement period,...

HOUSTON, Feb. 24, 2022 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) today announced its fourth quarter 2021 financial results. The announcement and financial schedules can be accessed via the Investor Relations section of the company’s website, oxy.com. The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call on Friday, February 25, 2022, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10162667/f0506288be. A recording of the webcast will be posted on the Investor Relations section of the website after the call is completed. About...